Home/Filings/4/0001437749-21-000133
4//SEC Filing

GORDON KEVIN K 4

Accession 0001437749-21-000133

CIK 0001384101other

Filed

Jan 4, 7:00 PM ET

Accepted

Jan 5, 5:00 PM ET

Size

10.0 KB

Accession

0001437749-21-000133

Insider Transaction Report

Form 4
Period: 2021-01-04
Transactions
  • Exercise/Conversion

    Common Stock

    2021-01-04$7.39/sh+10,000$73,90010,000 total
  • Sale

    Common Stock

    2021-01-04$48.62/sh4,477$217,6645,523 total
  • Sale

    Common Stock

    2021-01-04$49.27/sh5,523$272,1340 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2021-01-0410,00015,000 total
    Exercise: $7.39Exp: 2026-12-11Common Stock (10,000 underlying)
Footnotes (4)
  • [F1]The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on September 1, 2020.
  • [F2]Represents weighted average sales price. Sale prices for the transactions range from $48.02 to $49.00. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F3]Represents weighted average sales price. Sale prices for the transactions range from $49.04 to $49.56. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
  • [F4]The option is fully vested.

Issuer

VERACYTE, INC.

CIK 0001384101

Entity typeother

Related Parties

1
  • filerCIK 0001218483

Filing Metadata

Form type
4
Filed
Jan 4, 7:00 PM ET
Accepted
Jan 5, 5:00 PM ET
Size
10.0 KB